References
- Deray G, Carayon A, Maistre G, Benhmida M, Masson F, Barthelmy C, Petitclerc T, Jacobs C. Endothelin in chronic renal failure. Nephrol Dial Transplant 1992; 7: 300–305
- Gordge M P, Faint R W, Rylance P B, Neild G H. Platelet function and the bleeding time in progressive renal failure. Thromb Haemost 1988; 60: 83–87
- Hirata K, Yoshimi H, Takata S, Watanabe T X, Kumagai S, Nakajima K, Sakakibara S. Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 1988; 154: 868–875
- Battistini B, Filep J G, Herman F, Sirois P. Endothelin-1 does not affect human platelet aggregation in whole blood and platelet rich plasma. Thromb Res 1990; 60: 105–108
- Edlund A, Wennmalm A. Endothclin does not affect aggregation of human platelets. Clin Physiol 1990; 10: 585–590
- Joseph R, Scicli A G, Han E, Grunfeld S, Carretero O A, Welch K M. Endothelin-1 and human platelet activity. Thromb Res 1991; 61: 529–536
- Lidbury P S, Thiemermann C, Korbul R, Vane J R. Endothelins release tissue plasminogen activator and prostanoids. Eur J Pharmacol 1990; 21: 205–212
- Born G VR, Cross M. The aggregation of blood platelets. J Physiol 1961; 168: 178–195
- Born G VR. Aggregation of blood platelets by adenosinc diphosphate and its reversal. Nature 1962; 194: 927–929
- Koyama H, Nishzawa Y, Morii H, Tabata T, Inoue T, Yamaji T. Plasma ET levels in patients with uremia. Lancet 1989; 2: 991–992
- Warrens A N, Cassidy M JD, Takahashi K, Ghate M A, Bloom S R. ET in renal failure. Nephrol Dial Transplant 1990; 5: 418–422
- Heintz B, Dörr R, Gillessen T, Walkenhorst K, Krebs W, Hanrath P, Sieberth H G. Do arterial endothelin I levels affect local arterial stiffncss?. Am Heart J 1993; 126: 987–989
- Takayasu-Okishio M, Terashita Z, Kondo K. Endothelin-1 and platelet activating factor stimulate thromboxane A2 biosythesis in rat vascular smooth muscle cells. Biochem Pharmacol 1990; 40: 2713–2717
- Graber S E, Harwiger J. Evidence that changes in platelet cyclic AMP levels regulate the fibrinogen receptor on human platelets. J Biol Chem 1982; 257: 14606–14612
- Vlachoyoannis J, Schöppe W. Adenylate cyclase activity and cAMP content of human platelets in uraemia. Eur J din Invest 1982; 12: 379–381
- Yang M CM, Tu M S, Chou C K, Hong C Y, Kuo J S. cAMP and vascular action of endothelin. Pharmacology 1991; 42: 252–256